Gilead, manufacturer of the TROP2-directed antibody-drug conjugate sacituzumab govitecan, made the decision to withdraw the ...

Gilead is withdrawing the accelerated approval of Trodelvy (sacituzumab govitecan-hziy) for metastatic urothelial cancer.

Cigna and Humana are in early-stage merger discussions after a year-long pause. Amid financial pressure, Humana's Medicare ...

TD Cowen analyst Tyler Van Buren has maintained their bullish stance on GILD stock, giving a Buy rating today. Tyler Van Buren’s rating ...

"We are essentially moving from a situation of defeating the enemy in all the contact villages to a state of destruction." Information ...

With two weeks to go before the U.S. presidential election, cases of political violence have shown the biggest and most sustained increase since the 1970s. United Statescategory Nebraska ...

Judge, Soto and Stanton vs. Ohtani, Betts and Freeman! Here's your first look at what will decide a star-studded Fall Classic showdown. In the video, the backseat passengers can be seen trying to ...